Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HCA vs GSK✓SelectedUSD · GSKHCA vs GSK performance historyLatest closeAs of-3.36%11/19
Stock and ETF performance explorer

HCA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,902.6%
GSK return
+168.4%
Excess return
+1,734.3%
Maximum drawdown
-54.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.4%-1.6%-1.8%-2.7%
7D-8.1%-4.7%-3.3%-6.1%
30D-1.2%-4.7%+3.5%+0.9%
3M+13.3%-8.8%+22.1%+17.7%
6M+14.2%-4.6%+18.8%+16.4%
YTD-0.9%+1.0%-1.9%-2.0%
1Y-3.7%+6.9%-10.5%-7.1%
3Y+91.2%+52.5%+38.6%+53.2%
5Y+100.8%+40.3%+60.5%+64.3%
10Y+587.7%+99.0%+488.8%+371.6%
All+1,902.6%+168.4%+1,734.3%+1,027.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling